Technical Analysis for AVGR - Avinger, Inc.

Grade Last Price % Change Price Change
F 2.90 -0.34% -0.01
AVGR closed down 0.34 percent on Monday, March 18, 2024, on 18 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Mar 20
*** please verify all earnings dates ***
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
Stochastic Buy Signal Bullish 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
Oversold Stochastic Weakness 0.00%
50 DMA Resistance Bearish -0.34%
New Uptrend Bullish -0.34%
Calm After Storm Range Contraction -0.34%
Wide Bands Range Expansion -0.34%
Oversold Stochastic Weakness -0.34%

   Recent Intraday Alerts

Alert Time
Up 5% about 17 hours ago
Gap Up Closed about 17 hours ago
Down 1% about 17 hours ago
Reversed from Up about 17 hours ago
Possible NR7 about 18 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Avinger, Inc. Description

Avinger, Inc., a medical device company, designs, manufactures, and sells image-guided, catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD). It offers Lightbox, an imaging console, which enables the use of lumivascular catheters during PAD procedures; Ocelot, a chronic total occlusion (CTO) crossing catheter, which allows physicians to see the inside of an artery during a CTO crossing procedure; Ocelot PIXL, a lower profile CTO-crossing device for below-the-knee arteries; and Ocelot MVRX, a device which offers a tip design for above-the-knee arteries. The company also provides Wildcat, a catheter that facilitates the intraluminal placement of conventional guidewires beyond stenotic lesions in the peripheral vasculature prior to further percutaneous intervention; and Kittycat 2, a catheter that facilitate the intraluminal placement of conventional guidewires beyond stenotic lesions in the peripheral vasculature prior to further percutaneous intervention. The company offers its products to interventional cardiologists, vascular surgeons, and interventional radiologists directly in the United States and Europe. Avinger, Inc. was founded in 2007 and is headquartered in Redwood City, California.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Clinical Medicine Imaging Catheter Medical Imaging Interventional Radiology Knee Artery Cordis Interventional Cardiology Percutaneous Peripheral Arterial Disease

Is AVGR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 18.0
52 Week Low 2.5
Average Volume 60,993
200-Day Moving Average 5.87
50-Day Moving Average 3.11
20-Day Moving Average 3.52
10-Day Moving Average 3.21
Average True Range 0.39
RSI (14) 42.20
ADX 25.95
+DI 22.25
-DI 18.78
Chandelier Exit (Long, 3 ATRs) 4.28
Chandelier Exit (Short, 3 ATRs) 3.97
Upper Bollinger Bands 4.64
Lower Bollinger Band 2.40
Percent B (%b) 0.22
BandWidth 63.63
MACD Line -0.07
MACD Signal Line 0.04
MACD Histogram -0.1077
Fundamentals Value
Market Cap 3.71 Million
Num Shares 1.28 Million
EPS -30.21
Price-to-Earnings (P/E) Ratio -0.10
Price-to-Sales 0.48
Price-to-Book 1.56
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.20
Resistance 3 (R3) 3.23 3.15 3.15
Resistance 2 (R2) 3.15 3.07 3.14 3.14
Resistance 1 (R1) 3.02 3.02 2.99 3.00 3.12
Pivot Point 2.95 2.95 2.93 2.93 2.95
Support 1 (S1) 2.82 2.87 2.78 2.80 2.68
Support 2 (S2) 2.74 2.82 2.73 2.66
Support 3 (S3) 2.62 2.74 2.65
Support 4 (S4) 2.60